Publications

cemka > Publications

Sort publications on year

  • Pharmaco - Epidemiology

    Irritable bowel syndrome in France : quality of life, medical management, and costs : the Encoli Study

    BRUN-STRANG C, DAPOIGNY M, LAFUMA A, WAINSTEN JP, FAGNANI F

    Eur J Gastroenterol Hepatol ; 19(12):1097-1103

  • Pharmaco - Epidemiology

    Anogenital warts incidence, medical management and costs in women consulting gynaecologists in France

    MONSONEGO J, BREUGELMANS JG, BOUEE S, LAFUMA A, BENARD S, REMY V

    Gynécol Obstét Fertil ; 35:107-113

  • Pharmaco-Economics

    Evaluation économique du trastuzumab en traitement adjuvant du cancer du sein précoce surexprimant HER2

    FAGNANI F, COLIN X, ARVEUX P, COUDERT B, MISSET JL

    Bulletin du Cancer ; 94(7):711-720

  • Pharmaco - Epidemiology

    Epidemiology, impact, management and cost of Paget’s disease of bone in France

    SARAUX A, BRUN-STRANG C, MIMAUD V, VIGNERON AM, LAFUMA A

    Joint Bone Spine ; 74(1):90-95

  • Pharmaco-Economics

    CoĂ»t de l’obĂ©sitĂ© en France

    EMERY C, DINET J, LAFUMA A, SERMET C, KHOSHNOOD B, FAGNANI F

    Presse Med ; 832-840

  • Pharmaco-Economics

    Invasive cervical cancer treatment costs in France

    ARVEUX P, BENARD S, BOUEE S, LAFUMA A, MARTIN L, CRAVELLO L, REMY V, BREUGELMANS JG

    Bull Cancer ; 94(2):219-224

  • Pharmaco-Economics

    CoĂ»t de la prise en charge des frottis anormaux et des nĂ©oplasies intraĂ©pithĂ©liales du col de l’utĂ©rus en France

    BERGERON C, COHET C, BOUEE S, LORANS C, REMY V

    BEH ; (1):4-6

  • Biometry and database analysis

    Costs of cardiovascular events of diabetic patients in French hospitals

    COLIN X, LAFUMA A, GUERON B

    Diabetes Metab ; 2017;33(4):310-313

  • Pharmaco-Economics

    Costs and effectiveness of travoprost versus a dorzolamide + timolol fixed combination in first-line treatment of glaucoma : analysis conducted on the United Kingdom General Practitioner Research Database

    LAFUMA A, BERDEAUX G

    Curr Med Res Opin ; 23(12):3009-3016

  • Pharmaco-Economics

    Cost Consequences of Adjuvant Capecitabine, Mayo Clinic and de Gramont Regimens for Stage III Colon Cancer in the French Setting

    DOUILLARD JY, TILLEUL P,YCHOU M, DUFOUR P, PERROCHEAU G, SEITZ JF, MAES P, LAFUMA A, HUSSEINI F

    Oncology ; 72:248-254

  • Pharmaco-Economics

    A model of the public health impact of improved treatment persistence in post-meopausal osteoroposis in France

    COTTE FE, CORTET B, LAFUMA A, AVOUAC B, HASNAOUI AE, FADELLONE P, POUCHAIN D, ROUX C, GAUDIN AF

    Joint Bone Spine ; 31

  • Biometry and database analysis

    A meta-analysis of topical prostaglandin analogues intra-ocular pressure lowering in glaucoma therapy

    DENIS PH, LAFUMA A, KHOSHNOOD B, MIMAUD V, BERDEAUX G

    Curr Med Res Opin ; 23(3):601-608

  • Pharmaco - Epidemiology

    A benefit for renal function after early switch to liposomal amphotericin B from conventional formulation in empirical antifungal treatment

    ISNARD F, TILLEUL P, LAPORTE JF, CHEVALLIER P, PIGNEUX A, LAFUMA A, MAHI L, DERAY G

    Nephrol Dial Transplant ; 22(10):3090-3091

  • Public Health and Epidemiology

    Evaluation of a screening programme for diabetic retinopathy (DODIA study).

    AUBERT JP, MASSIN P, AUDRAN G, BEN MEHIDI A, BERNIT B, BOUÉE S, BOUHASSIRA M, BOUROVITCH JC, ERGINAY A, ESCHWEGE E, JAMET M, MARRE M, NOUGAIRÈDE M, TCHERNY-LESSENOT S

    Rev Prat. ; 57(11):1203-1209

  • Pharmaco - Epidemiology

    StratĂ©gie diagnostique de l’infection par le VHC en mĂ©decine gĂ©nĂ©rale : Etats des lieux, nature des obstacles rencontrĂ©s – Etude GYMKHANA 1 (2Ăšme partie)

    AUBERT JP, BOUEE S, BENTATA M, COMPAGNON M, ELGHOZI B, LIVROZET JM, MECHALI D, PERDRIEAU F, PY AM, ROZEMBAUM W, TAULERA O, WAJSBROT A

    Rev Prat - Médecine Générale ; 20(726/727):386-391